Elevance Health, Inc.
396.90USD
-5.0400 (-1.25%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 156.6B | 171.3B | 177.0B | 199.1B | 196.2B | 200.4B |
| Q1 | 38.1B | 42.2B | 42.6B | 48.9B | 50.2B | — |
| Q2 | 38.6B | 43.7B | 43.9B | 49.8B | 50.5B | — |
| Q3 | 39.9B | 42.8B | 45.1B | 50.7B | 49.1B | — |
| Q4 | 39.9B | 42.6B | 45.4B | 49.7B | 48.1B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 24.28 | 25.22 | 25.68 | 25.21 | 27.16 | 29.61 |
| Q1 | 7.32 | 8.30 | 9.59 | 9.61 | 8.00 | — |
| Q2 | 6.73 | 7.79 | 9.85 | 7.72 | 6.71 | — |
| Q3 | 6.62 | 5.45 | 4.36 | 5.32 | 4.66 | — |
| Q4 | 3.61 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 3.66 |
| 1.87 |
| 2.54 |
| 2.47 |
| — |